Pikesville, MD, United States of America

Ira H Gewolb


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 50(Granted Patents)


Company Filing History:


Years Active: 1999-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Ira H Gewolb

Introduction

Ira H Gewolb is a notable inventor based in Pikesville, MD (US). He has made significant contributions to the field of gastrointestinal health, particularly in the prevention and treatment of neonatal necrotizing enterocolitis (NEC). Gewolb holds two patents that showcase his innovative approaches to improving health outcomes for vulnerable populations, including preterm infants.

Latest Patents

Gewolb's latest patents focus on two key methods for preventing and treating NEC. The first patent involves administering Lactobacilli strains, specifically Lactobacillus salivarius strain ATCC 202196 and Lactobacillus plantarum strain ATCC 202195. These strains are effective in preventing gastrointestinal tissue injury and infections in preterm infants. They can be administered in various forms, including lyophilized capsules and via naso-gastric tubes. The second patent details the use of oral glutamine to prevent necrotizing tissue injury in the gastrointestinal tract. Glutamine serves to protect tissues by blocking the translocation of harmful bacterial agents and optimizing mucosal defense.

Career Highlights

Ira H Gewolb is associated with Probiotix, Inc., where he continues to develop innovative solutions for gastrointestinal health. His work has the potential to significantly impact the treatment of NEC and other gastrointestinal dysfunctions, providing safer options for infants and children.

Collaborations

Gewolb collaborates with esteemed colleagues in the field, including Pinaki Panigrahi and J Glenn Morris. Their combined expertise enhances the research and development of effective treatments for gastrointestinal conditions.

Conclusion

Ira H Gewolb's contributions to the field of gastrointestinal health through his innovative patents demonstrate his commitment to improving health outcomes for infants and children. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…